NCT02851108View on ClinicalTrials.gov

Methylene Blue Against Falciparum Malaria in Burkina Faso

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

December 31, 2016

Study Completion Date

February 28, 2017

Conditions
Malaria, Falciparum
Interventions
DRUG

Methylene Blue

50 patients will receive methylene blue

DRUG

Primaquine

50 patients will receive primaquine

Trial Locations (1)

Unknown

CRSN, Nouna

All Listed Sponsors
collaborator

Centre de Recherche en Sante de Nouna, Burkina Faso

OTHER_GOV

lead

Heidelberg University

OTHER

NCT02851108 - Methylene Blue Against Falciparum Malaria in Burkina Faso | Biotech Hunter | Biotech Hunter